Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
2d
Delcath Systems: Strong Financial Performance and Promising Outlook Justify Buy Rating
John Newman, an analyst from Canaccord Genuity, maintained the Buy rating on Delcath Systems (DCTH – Research Report). The associated price ...
2d
Pfizer’s Growth Potential and Strategic Focus Justify Buy Rating Amid Healthcare Policy Shifts
Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Pfizer (PFE – Research Report) and keeping the price target at $36.00.Stay ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Accused of sexual assault
Delivers farewell address
Texas sheriff's deputy killed
Asks Trump for help
US recovers $31 million
Denied bail by NY judge
Doctor sentenced for abuse
Pentagon faults secrecy
Kilauea eruption in Hawaii
Population projections drop
FTC sues Deere & Co.
2 men jailed for Wactor case
Reaches orbit on first flight
France extradites US suspect
SC jail federal report
Replaced as LIV Golf CEO
Assets hit record $11.6T
Launches DNC chair bid
UK's Starmer in Kyiv
US closes safety probe
Sued over flight delays
Unveils new pursuit policy
Drake sues Universal Music
Cartel leader in plea talks
Removed as intel chairman
NJ stockpiling abortion pills
Pro-Abrams groups fined
Feedback